WHO ICTRP trial
An investigation of the efficacy of a single dose of insulin in the prevention…
EUCTR2010-022290-34-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-022290-34-GB |
|---|---|
| Public title | An investigation of the efficacy of a single dose of insulin in the prevention of excessive cutaneous scarring in breast surgery patients - Insulin as anti-scarring agent - breast surgery group |
| Scientific title | An investigation of the efficacy of a single dose of insulin in the prevention of excessive cutaneous scarring in breast surgery patients - Insulin as anti-scarring agent - breast surgery group |
| Primary sponsor | Pharmecosse |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): Therapeutic use (Phase IV): |
| Countries | United Kingdom |
| Conditions | Scarring arising from non cancer-related bilateral breast surgery |
| Interventions | Trade Name: Insulatard Pharmaceutical Form: Injection* INN or Proposed INN: Insulin Human rDNA Concentration unit: IU/ml international unit(s)/millilitre Concentration type: equal Concentration number: 100- |
| Registration date | Apr 10, 2010 |
| Target size | 75 |
| Secondary IDs | 10-001;ISRCTN51295799 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: